230 related articles for article (PubMed ID: 1499081)
1. Sulfotransferase-mediated DNA binding of N-hydroxyarylamines(amide) in liver cytosols from human and experimental animals.
Abu-Zeid M; Yamazoe Y; Kato R
Carcinogenesis; 1992 Aug; 13(8):1307-14. PubMed ID: 1499081
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic acetylation and sulfation of N-hydroxyarylamines in bacteria and rat livers.
Yamazoe Y; Abu-Zeid M; Gong DW; Staiano N; Kato R
Carcinogenesis; 1989 Sep; 10(9):1675-9. PubMed ID: 2670304
[TBL] [Abstract][Full Text] [Related]
3. Acetyl coenzyme A dependent activation of N-hydroxy derivatives of carcinogenic arylamines: mechanism of activation, species difference, tissue distribution, and acetyl donor specificity.
Shinohara A; Saito K; Yamazoe Y; Kamataki T; Kato R
Cancer Res; 1986 Sep; 46(9):4362-7. PubMed ID: 3731093
[TBL] [Abstract][Full Text] [Related]
4. Activation and detoxication of carcinogenic arylamines by sulfation.
Yamazoe Y; Nagata K; Ozawa S; Gong DW; Kato R
Princess Takamatsu Symp; 1995; 23():154-62. PubMed ID: 8844806
[TBL] [Abstract][Full Text] [Related]
5. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s).
Chou HC; Lang NP; Kadlubar FF
Cancer Res; 1995 Feb; 55(3):525-9. PubMed ID: 7834621
[TBL] [Abstract][Full Text] [Related]
6. Hepatic metabolism of N-hydroxy-N-methyl-4-aminoazobenzene and other N-hydroxy arylamines to reactive sulfuric acid esters.
Kadlubar FF; Miller JA; Miller EC
Cancer Res; 1976 Jul; 36(7 PT 1):2350-9. PubMed ID: 819129
[TBL] [Abstract][Full Text] [Related]
7. Acetyltransferase and sulfotransferase which activate mutagens and carcinogens through O-esterification mechanisms.
Yamazoe Y; Abu-Zeid M; Gong DW; Ozawa S; Nagata K; Kato R
Princess Takamatsu Symp; 1990; 21():109-17. PubMed ID: 2134670
[TBL] [Abstract][Full Text] [Related]
8. Enhancement by cysteinyl thiols of acetyltransferase-mediated, but not of sulfotransferase-mediated, binding of a pyrolysate-derived N-hydroxyarylamine, 2-hydroxyamino-6-methyldipyrido[1,2-a:3',2'-d]imidazole, to DNA.
Abu-Zeid M; Staiano N; Yamazoe Y; Kato R
Jpn J Cancer Res; 1990; 81(6-7):653-9. PubMed ID: 2119366
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic phase II activation of the N-hydroxylamines of IQ, MeIQx and PhIP by various organs of monkeys and rats.
Davis CD; Schut HA; Snyderwine EG
Carcinogenesis; 1993 Oct; 14(10):2091-6. PubMed ID: 8222059
[TBL] [Abstract][Full Text] [Related]
10. Activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b] pyridine by cDNA-expressed human and rat arylsulfotransferases.
Ozawa S; Chou HC; Kadlubar FF; Nagata K; Yamazoe Y; Kato R
Jpn J Cancer Res; 1994 Dec; 85(12):1220-8. PubMed ID: 7852185
[TBL] [Abstract][Full Text] [Related]
11. DNA binding of N-hydroxy-Trp-P-2 and N-hydroxy-Glu-P-1 by acetyl-CoA dependent enzyme in mammalian liver cytosol.
Shinohara A; Saito K; Yamazoe Y; Kamataki T; Kato R
Carcinogenesis; 1985 Feb; 6(2):305-7. PubMed ID: 3971494
[TBL] [Abstract][Full Text] [Related]
12. Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyltransferases.
Flammang TJ; Kadlubar FF
Carcinogenesis; 1986 Jun; 7(6):919-26. PubMed ID: 3708755
[TBL] [Abstract][Full Text] [Related]
13. Sulfation of hydroxylamines and hydroxamic acids in liver cytosol from male and female rats and purified aryl sulfotransferase IV.
Gilissen RA; Ringer DP; Stavenuiter HJ; Mulder GJ; Meerman JH
Carcinogenesis; 1992 Oct; 13(10):1699-703. PubMed ID: 1423828
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of acetyl-coenzyme A dependent activation of N-hydroxyarylamines by phenolic compounds, pentachlorophenol and 1-nitro-2-naphthol.
Shinohara A; Saito K; Yamazoe Y; Kamataki T; Kato R
Chem Biol Interact; 1986 Dec; 60(3):275-85. PubMed ID: 3791493
[TBL] [Abstract][Full Text] [Related]
15. Mutagenicity and in vitro covalent DNA binding of 2-hydroxyamino-3-methylimidazolo[4,5-f]quinoline.
Snyderwine EG; Wirth PJ; Roller PP; Adamson RH; Sato S; Thorgeirsson SS
Carcinogenesis; 1988 Mar; 9(3):411-8. PubMed ID: 3162208
[TBL] [Abstract][Full Text] [Related]
16. Sulfation of carcinogenic aromatic hydroxylamines and hydroxamic acids by rat and human sulfotransferases: substrate specificity, developmental aspects and sex differences.
Meerman JH; Ringer DP; Coughtrie MW; Bamforth KJ; Gilissen RA
Chem Biol Interact; 1994 Jun; 92(1-3):321-8. PubMed ID: 8033265
[TBL] [Abstract][Full Text] [Related]
17. Sulfation of aromatic hydroxamic acids and hydroxylamines by multiple forms of human liver sulfotransferases.
Gilissen RA; Bamforth KJ; Stavenuiter JF; Coughtrie MW; Meerman JH
Carcinogenesis; 1994 Jan; 15(1):39-45. PubMed ID: 8293546
[TBL] [Abstract][Full Text] [Related]
18. N-sulfoöxy-2-aminofluorene is the major ultimate electrophilic and carcinogenic metabolite of N-hydroxy-2-acetylaminofluorene in the livers of infant male C57BL/6J x C3H/HeJ F1 (B6C3F1) mice.
Lai CC; Miller JA; Miller EC; Liem A
Carcinogenesis; 1985 Jul; 6(7):1037-45. PubMed ID: 3860305
[TBL] [Abstract][Full Text] [Related]
19. Isolation and expression of a cDNA encoding a male-specific rat sulfotransferase that catalyzes activation of N-hydroxy-2-acetylaminofluorene.
Nagata K; Ozawa S; Miyata M; Shimada M; Gong DW; Yamazoe Y; Kato R
J Biol Chem; 1993 Nov; 268(33):24720-5. PubMed ID: 8227031
[TBL] [Abstract][Full Text] [Related]
20. Initiation of hepatocarcinogenesis in infant male B6C3F1 mice by N-hydroxy-2-aminofluorene or N-hydroxy-2-acetylaminofluorene depends primarily on metabolism to N-sulfooxy-2-aminofluorene and formation of DNA-(deoxyguanosin-8-yl)-2-aminofluorene adducts.
Lai CC; Miller EC; Miller JA; Liem A
Carcinogenesis; 1987 Mar; 8(3):471-8. PubMed ID: 3815742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
